NRIX   $14.43  -3.28% Market Closed After Close 14.43 0.0

Nurix Therapeutics, Inc.
Total Cash 448.05M
totalCashPerShare 6.325
EBITDA -186.40M
Total Debt 27.14M
quickRatio 5.201
currentRatio 5.285
Total Revenue 56.42M
debtToEquity 7.202
Revenue/Share 0.922
ROA -0.29464
ROE -0.57961
grossProfits
freeCashflow -56.77M
operatingCashflow -97.14M
earningsGrowth
revenueGrowth -0.318
grossMargins -2.61763
ebitdaMargins 0.0
operatingMargins -4.3383403
profitMargins 0.0
enterpriseValue 1.38B
forwardPE -9.712231
floatShares 57.48M
sharesOutstanding 70.84M
sharesShort 9.24M
sharesShortPriorMonth 9.36M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.95%
Short Ratio help_outline 11.30%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue 5.618
Price To Book help_outline 4.81
earningsQuarterlyGrowth
netIncomeToCommon -176.98M
trailingEps -2.90%
forwardEps -2.78%
enterpriseToEbitda -7.41
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.67 4Q 2024
institutionsCount 254
lastUpdated Nov. 7, 2024, 3:19 a.m.